The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): An open-label, single-arm, phase 2 study.
 
Zhigong Wei
No Relationships to Disclose
 
Huijiao Chen
No Relationships to Disclose
 
Lei Cai
No Relationships to Disclose
 
Fei Chen
No Relationships to Disclose
 
Jun Liu
No Relationships to Disclose
 
Xingchen Peng
No Relationships to Disclose